Syra Health Corp.
SYRA Healthcare Medical Care Facilities
Syra Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.2 million, down 9.47% from fiscal 2024.
- Revenue
- +51.5%
- EPS
- +221.5%
- Free cash flow
- +235.8%
Quarter to September 2026, against a year earlier
Follow SYRA
Alert me
Syra Health Corp. (SYRA) P/E ratio
As of 6 November 2026, Syra Health Corp. (SYRA) trades at a P/E ratio of 14.7×. Over the past ten years it has ranged from 0.0× (June 2026) to 105× (July 2026); the current reading is higher than 88% of that period. That is below the Medical Care Facilities industry median of 18.7× and below the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 16.2× | (74.68%) |
| Jun 2026 | 64.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 12 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| DCGO DocGo Inc. compare | n/m |
| CCM Concord Medical Services Holdings Limited compare | n/m |
| NVOS Novo Integrated Sciences, Inc. compare | n/m |
| AMS American Shared Hospital Services compare | n/m |
| PIII P3 Health Partners Inc. compare | n/m |
| RHEP Adcare Health Systems Inc compare | 0.6× |
| BTMD biote Corp. compare | 6.6× |
| SYRA Syra Health Corp. | 14.7× |
| NIVF NewGenIvf Group Limited compare | — |
| Medical Care Facilities industry median | 18.7× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)